Insider Transactions in Q1 2022 at Natures Sunshine Products Inc (NATR)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 30
2022
|
Daniel C Norman EVP & President, Asia |
SELL
Payment of exercise price or tax liability
|
Direct |
844
-1.38%
|
$13,504
$16.79 P/Share
|
|
Mar 30
2022
|
Bryant J Yates EVP & President, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
844
-1.13%
|
$13,504
$16.79 P/Share
|
|
Mar 30
2022
|
Nathan G Brower EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
573
-1.43%
|
$9,168
$16.79 P/Share
|
|
Mar 30
2022
|
Edward Silcock EVP & President, North America |
SELL
Payment of exercise price or tax liability
|
Direct |
829
-2.35%
|
-
|
|
Mar 30
2022
|
Joseph W Baty EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,811
-1.87%
|
$44,976
$16.79 P/Share
|
|
Mar 29
2022
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,267
-2.93%
|
$191,539
$17.15 P/Share
|
|
Mar 26
2022
|
Nathan G Brower EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
637
-1.57%
|
$10,829
$17.23 P/Share
|
|
Mar 26
2022
|
Joseph W Baty EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,181
-0.78%
|
$20,077
$17.23 P/Share
|
|
Mar 26
2022
|
Daniel C Norman EVP & President, Asia |
SELL
Payment of exercise price or tax liability
|
Direct |
614
-0.99%
|
$10,438
$17.23 P/Share
|
|
Mar 26
2022
|
Edward Silcock EVP & President, North America |
SELL
Payment of exercise price or tax liability
|
Direct |
776
-2.16%
|
$13,192
$17.23 P/Share
|
|
Mar 26
2022
|
Bryant J Yates EVP & President, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
614
-0.82%
|
$10,438
$17.23 P/Share
|
|
Mar 18
2022
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,147
-1.32%
|
$87,499
$17.03 P/Share
|
|
Mar 18
2022
|
Terrence Moorehead Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,077
+3.25%
|
-
|
|
Mar 02
2022
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,389
-0.63%
|
$40,613
$17.42 P/Share
|
|
Mar 02
2022
|
Terrence Moorehead Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,804
+2.52%
|
-
|
|
Mar 02
2022
|
Joseph W Baty EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,226
-0.8%
|
$20,842
$17.42 P/Share
|
|
Mar 02
2022
|
Joseph W Baty EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,482
+2.86%
|
-
|
|
Jan 25
2022
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,177
-0.85%
|
$54,009
$17.86 P/Share
|
|
Jan 25
2022
|
Terrence Moorehead Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,077
+3.39%
|
-
|
|
Jan 21
2022
|
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
25,000
+25.15%
|
$200,000
$8.72 P/Share
|
|
Jan 14
2022
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,790
-0.77%
|
$50,220
$18.61 P/Share
|
|
Jan 14
2022
|
Terrence Moorehead Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,804
+2.64%
|
-
|
|
Jan 14
2022
|
Joseph W Baty EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,463
-0.98%
|
$26,334
$18.61 P/Share
|
|
Jan 14
2022
|
Joseph W Baty EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,481
+2.91%
|
-
|
|
Jan 07
2022
|
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
9,558
+16.21%
|
-
|
|
Jan 03
2022
|
Tess Roering Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,155
+50.0%
|
-
|
|
Jan 03
2022
|
Curtis Kopf Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,155
+50.0%
|
-
|
|
Jan 03
2022
|
Joseph W Baty EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,526
-1.04%
|
$27,468
$18.5 P/Share
|